TTIPF
Thiogenesis Therapeutics Corp.
Price Chart
Latest Quote
$0.45
+0.00 (+0.00%)
Current Price
| Previous Close | $0.45 |
| Open | $0.45 |
| Day High | $0.45 |
| Day Low | $0.45 |
| Volume | 1,000 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 51.84M |
| Cash Equivalents | $2.54M |
| Net Income | $-4.95M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $20.02M |
| EPS (TTM) | $-0.11 |
| Exchange | OQX |
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.45 | 0 |
| 2026-06-03 | $0.45 | 0 |
| 2026-06-02 | $0.45 | 0 |
| 2026-06-01 | $0.45 | 8,000 |
| 2026-05-29 | $0.45 | 0 |
| 2026-05-28 | $0.45 | 2,000 |
| 2026-05-27 | $0.43 | 0 |
| 2026-05-26 | $0.43 | 0 |
| 2026-05-22 | $0.43 | 0 |
| 2026-05-21 | $0.43 | 0 |
| 2026-05-20 | $0.43 | 0 |
| 2026-05-19 | $0.43 | 0 |
| 2026-05-18 | $0.43 | 0 |
| 2026-05-15 | $0.43 | 0 |
| 2026-05-14 | $0.43 | 0 |
| 2026-05-13 | $0.43 | 0 |
| 2026-05-12 | $0.43 | 0 |
| 2026-05-11 | $0.43 | 0 |
| 2026-05-08 | $0.43 | 0 |
| 2026-05-07 | $0.43 | 1,107 |
| 2026-05-06 | $0.41 | 0 |
| 2026-05-05 | $0.41 | 0 |
About Thiogenesis Therapeutics Corp.
Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. Its lead product candidate is TTI-0102, a prodrug that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke-like episodes, leigh syndrome, pediatric metabolic dysfunction-associated steatohepatitis, and rett syndrome. The company is headquartered in Toronto, Canada.
đ° Latest News
kneat.com Spotlights ARR Surge to CAD 74M, New Strategic Customers and AI Rollout at Conference
MarketBeat âĸ 2026-04-07T20:02:32Z
Is Thiogenesis Therapeutics (CVE:TTI) In A Good Position To Deliver On Growth Plans?
Simply Wall St. âĸ 2025-12-01T13:48:56Z
Foraco International And 2 Other TSX Penny Stocks To Watch
Simply Wall St. âĸ 2025-06-13T19:05:12Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-02-28 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $3,579,274 | $5,206,021 | $1,974,847 | $224,678 |
| Other Income Expense | $233,217 | $-28,155 | $-1,951,462 | - |
| Net Non Operating Interest Income Expense | $200,327 | $171,165 | $2,058 | $221 |
| Operating Expense | $3,579,274 | $5,206,021 | $1,974,847 | $224,678 |
| General And Administrative Expense | $1,355,939 | $1,043,064 | $933,087 | $218,210 |
| Interest Expense | - | $0 | $4,123 | $26 |
| Interest Expense Non Operating | - | $0 | $4,123 | $26 |
| Other Non Operating Income Expenses | - | - | $-2,007,653 | - |
| Other Operating Expenses | - | - | $-34,132 | $6,468 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Net Interest Income | $200,327 | $171,165 | $2,058 | $221 |
| Interest Income | $200,327 | $171,165 | $6,181 | $247 |
| Normalized Income | $-3,378,947 | $-5,034,856 | $-1,972,789 | $-224,457 |
| Net Income From Continuing And Discontinued Operation | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Net Income Common Stockholders | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Net Income | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Net Income Including Noncontrolling Interests | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Net Income Continuous Operations | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Pretax Income | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Interest Income Non Operating | $200,327 | $171,165 | $6,181 | $247 |
| Operating Income | $-3,579,274 | $-5,206,021 | $-1,974,847 | $-224,678 |
| Special Income Charges | - | $0 | $-2,012,927 | - |
| Per Share | ||||
| Diluted EPS | $-0.07 | $-0.13 | $-0.16 | $-0.01 |
| Basic EPS | $-0.07 | $-0.13 | $-0.16 | $-0.01 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,812,491 | $-5,177,866 | $-1,968,666 | $-224,431 |
| Total Unusual Items | $233,217 | $-28,155 | $-1,951,462 | - |
| Total Unusual Items Excluding Goodwill | $233,217 | $-28,155 | $-1,951,462 | - |
| EBITDA (Bullshit earnings) | $-3,579,274 | $-5,206,021 | $-3,920,128 | $-224,431 |
| EBIT | $-3,579,274 | $-5,206,021 | $-3,920,128 | $-224,431 |
| Diluted Average Shares | $45,360,652 | $39,129,334 | $25,291,554 | $27,910,175 |
| Basic Average Shares | $45,360,652 | $39,129,334 | $25,291,554 | $27,910,175 |
| Diluted NI Availto Com Stockholders | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Gain On Sale Of Security | $233,217 | $-28,155 | $61,465 | - |
| Research And Development | $2,223,335 | $4,162,957 | $1,075,892 | - |
| Selling General And Administration | $1,355,939 | $1,043,064 | $933,087 | $218,210 |
| Other Gand A | $980,582 | $665,750 | $538,622 | $218,210 |
| Salaries And Wages | $375,357 | $377,314 | $394,465 | - |
| Other Special Charges | - | - | $2,012,927 | - |
| Restructuring And Mergern Acquisition | - | - | $2,007,653 | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-02-28 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,425,512 | $5,530,134 | $5,983,421 | $-61,066 |
| Total Assets | $3,983,388 | $7,243,000 | $6,290,572 | $3,431,360 |
| Total Non Current Assets | $0 | $0 | $0 | $0 |
| Current Assets | $3,983,388 | $7,243,000 | $6,290,572 | $3,431,360 |
| Prepaid Assets | $47,596 | $81,377 | $38,624 | $25,000 |
| Receivables | $87,928 | $85,315 | $55,987 | $247 |
| Taxes Receivable | $85,315 | $79,312 | $13,927 | - |
| Accounts Receivable | $2,613 | $6,003 | $7,318 | - |
| Cash Cash Equivalents And Short Term Investments | $3,847,864 | $7,076,308 | $6,195,961 | - |
| Cash And Cash Equivalents | $3,847,864 | $7,076,308 | $6,195,961 | - |
| Other Receivables | - | - | $34,742 | - |
| Restricted Cash | - | - | - | $3,406,113 |
| Accrued Interest Receivable | - | - | - | $247 |
| Debt | ||||
| Net Debt | - | - | - | - |
| Total Debt | - | - | - | - |
| Current Debt And Capital Lease Obligation | - | - | - | - |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $557,876 | $1,712,866 | $307,151 | $3,492,426 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $557,876 | $1,712,866 | $307,151 | $3,492,426 |
| Payables And Accrued Expenses | $557,876 | $1,712,866 | $307,151 | $3,492,426 |
| Current Notes Payable | - | - | $0 | - |
| Payables | - | - | - | $3,246,718 |
| Other Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $3,425,512 | $5,530,134 | $5,983,421 | $-61,066 |
| Total Equity Gross Minority Interest | $3,425,512 | $5,530,134 | $5,983,421 | $-61,066 |
| Stockholders Equity | $3,425,512 | $5,530,134 | $5,983,421 | $-61,066 |
| Gains Losses Not Affecting Retained Earnings | $1,572,545 | $1,657,734 | $1,032,698 | - |
| Other Equity Adjustments | $1,572,545 | $1,657,734 | $1,032,698 | - |
| Retained Earnings | $-14,283,760 | $-11,138,030 | $-6,177,452 | $-453,423 |
| Other | ||||
| Ordinary Shares Number | $46,017,375 | $44,570,575 | $38,862,075 | $27,910,175 |
| Share Issued | $46,017,375 | $44,570,575 | $38,862,075 | $27,910,175 |
| Tangible Book Value | $3,425,512 | $5,530,134 | $5,983,421 | $-61,066 |
| Invested Capital | $3,425,512 | $5,530,134 | $5,983,421 | $-61,066 |
| Working Capital | $3,425,512 | $5,530,134 | $5,983,421 | $-61,066 |
| Total Capitalization | $3,425,512 | $5,530,134 | $5,983,421 | $-61,066 |
| Capital Stock | $16,136,727 | $15,010,430 | $11,128,175 | $302,473 |
| Common Stock | $16,136,727 | $15,010,430 | $11,128,175 | $302,473 |
| Additional Paid In Capital | - | - | - | $89,884 |
| Current Accrued Expenses | - | - | - | $245,708 |
| Dueto Related Parties Current | - | - | - | $3,246,718 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-02-28 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-3,920,570 | $-3,248,463 | $-2,089,693 | $-67,076 |
| Operating Activities | ||||
| Operating Cash Flow | $-3,920,570 | $-3,248,463 | $-2,089,693 | $-67,076 |
| Cash Flow From Continuing Operating Activities | $-3,920,570 | $-3,248,463 | $-2,089,693 | $-67,076 |
| Operating Gains Losses | - | - | $-56,191 | - |
| Investing Activities | ||||
| Investing Cash Flow | - | $0 | $107,457 | - |
| Cash Flow From Continuing Investing Activities | - | $0 | $107,457 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $4,121,226 | $4,879,970 | - |
| Financing Cash Flow | $723,400 | $4,121,226 | $8,126,631 | $3,326,758 |
| Cash Flow From Continuing Financing Activities | $723,400 | $4,121,226 | $8,126,631 | $3,326,758 |
| Net Common Stock Issuance | $0 | $4,121,226 | $4,879,970 | - |
| Common Stock Issuance | $0 | $4,121,226 | $4,879,970 | - |
| Net Other Financing Charges | - | - | - | $-194,542 |
| Other | ||||
| End Cash Position | $3,847,864 | $7,076,308 | $6,195,961 | $3,406,113 |
| Beginning Cash Position | $7,076,308 | $6,195,961 | $62,549 | $146,431 |
| Effect Of Exchange Rate Changes | $-31,274 | $7,584 | $-10,983 | - |
| Changes In Cash | $-3,197,170 | $872,763 | $6,144,395 | $3,259,682 |
| Proceeds From Stock Option Exercised | $723,400 | $0 | $3,421,833 | $3,521,300 |
| Change In Working Capital | $-1,123,822 | $1,333,634 | $-568,807 | $157,381 |
| Change In Payables And Accrued Expense | $-1,154,990 | $1,405,715 | $-642,663 | $182,628 |
| Change In Prepaid Assets | $33,781 | $-42,753 | $-38,624 | - |
| Change In Receivables | $-2,613 | $-29,328 | $112,480 | $-25,247 |
| Changes In Account Receivables | $-2,613 | $-64,070 | $-7,991 | - |
| Stock Based Compensation | $348,982 | $480,914 | $524,366 | - |
| Net Income From Continuing Operations | $-3,145,730 | $-5,063,011 | $-3,924,251 | $-224,457 |
| Repayment Of Debt | - | $0 | $-175,172 | - |
| Net Issuance Payments Of Debt | - | $0 | $-175,172 | - |
| Net Short Term Debt Issuance | - | $0 | $-175,172 | - |
| Short Term Debt Payments | - | $0 | $-175,172 | - |
| Net Business Purchase And Sale | - | $0 | $107,457 | - |
| Sale Of Business | - | $0 | $107,457 | - |
| Change In Payable | - | $1,405,715 | $-642,663 | - |
| Change In Account Payable | - | $1,405,715 | $-642,663 | - |
| Other Non Cash Items | - | - | $1,935,190 | - |
| Gain Loss On Investment Securities | - | - | $-61,465 | - |
| Change In Accrued Expense | - | - | - | $182,628 |
| Issuance Of Debt | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
Fetched: 2026-02-02